172 related articles for article (PubMed ID: 37460052)
1. Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing.
Habib MZ; Elnahas EM; Aboul-Ela YM; Ebeid MA; Tarek M; Sadek DR; Negm EA; Abdelhakam DA; Aboul-Fotouh S
Eur J Pharmacol; 2023 Sep; 955():175916. PubMed ID: 37460052
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
Mishra A; Singla R; Kumar R; Sharma A; Joshi R; Sarma P; Kaur G; Prajapat M; Bhatia A; Medhi B
ACS Chem Neurosci; 2022 Oct; 13(20):2942-2961. PubMed ID: 36166499
[TBL] [Abstract][Full Text] [Related]
3. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
[TBL] [Abstract][Full Text] [Related]
4. ADAR2-dependent GluA2 editing regulates cocaine seeking.
Schmidt HD; McFarland KN; Darnell SB; Huizenga MN; Sangrey GR; Cha JH; Pierce RC; Sadri-Vakili G
Mol Psychiatry; 2015 Nov; 20(11):1460-6. PubMed ID: 25349168
[TBL] [Abstract][Full Text] [Related]
5. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
6. A new strategy to increase RNA editing at the Q/R site of GluA2 AMPA receptor subunits by targeting alternative splicing patterns of ADAR2.
Chaytow H; Sethw Hassan I; Akbar S; Popplewell L; Dickson G; Chen PE
J Neurosci Methods; 2021 Dec; 364():109357. PubMed ID: 34536489
[TBL] [Abstract][Full Text] [Related]
7. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
[TBL] [Abstract][Full Text] [Related]
8.
Wu HF; Chen PS; Hsu YT; Lee CW; Wang TF; Chen YJ; Lin HC
Mol Neurobiol; 2018 Jun; 55(6):4811-4824. PubMed ID: 28733898
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma.
Wang AL; Carroll RC; Nawy S
PLoS One; 2014; 9(3):e91288. PubMed ID: 24608178
[TBL] [Abstract][Full Text] [Related]
10. Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease.
Gaisler-Salomon I; Kravitz E; Feiler Y; Safran M; Biegon A; Amariglio N; Rechavi G
Neurobiol Aging; 2014 Aug; 35(8):1785-91. PubMed ID: 24679603
[TBL] [Abstract][Full Text] [Related]
11. Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons.
Bonini D; Filippini A; La Via L; Fiorentini C; Fumagalli F; Colombi M; Barbon A
RNA Biol; 2015; 12(1):43-53. PubMed ID: 25625181
[TBL] [Abstract][Full Text] [Related]
12. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC
Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381
[TBL] [Abstract][Full Text] [Related]
13. A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia.
Kubota-Sakashita M; Iwamoto K; Bundo M; Kato T
Mol Brain; 2014 Jan; 7():5. PubMed ID: 24443933
[TBL] [Abstract][Full Text] [Related]
14. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
[TBL] [Abstract][Full Text] [Related]
15. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
Hosaka T; Tsuji H; Kwak S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
[TBL] [Abstract][Full Text] [Related]
16. Zebrafish Adar2 Edits the Q/R site of AMPA receptor Subunit gria2α transcript to ensure normal development of nervous system and cranial neural crest cells.
Li IC; Chen YC; Wang YY; Tzeng BW; Ou CW; Lau YY; Wu KM; Chan TM; Lin WH; Hwang SP; Chow WY
PLoS One; 2014; 9(5):e97133. PubMed ID: 24818983
[TBL] [Abstract][Full Text] [Related]
17. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977
[TBL] [Abstract][Full Text] [Related]
18. Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GAM; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110522. PubMed ID: 35131336
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
[TBL] [Abstract][Full Text] [Related]
20. Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 editing.
Mahajan SS; Thai KH; Chen K; Ziff E
Neuroscience; 2011 Aug; 189():305-15. PubMed ID: 21620933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
